 |
Injex 30 is the latest technology and trend
now. This treatment is also known as mesotherapy. Mesotherapy is beigng
said as a substitite to botox which is needle -free, non-toxc and
100% safe. Mesotherapy is a release of pressure with supersonic speed
enter into skin derma layer which give inmediate result without any
pain.
Advantages of Mesotherapy
- Improve patient acceptance of therapy – Let’s face it,
no one likes injections with needles! By eliminating the needle from
injection therapies, the net result is better acceptance by patients.
- Increase patient compliance – Better acceptance leads to better
compliance. By eliminating the “fear factor” from taking
injections, patients will be less likely to skip a dose or delay treatment.
- Eliminate risks of sharps injuries and disposal hassles –
Recent Federal and State legislation has mandated the use of safety
injection products in healthcare facilities. Mesotherapy is a primary
prevention tool that eliminates the risk of accidental needle stick
injuries and disposal risks associated with needle syringes.
- Product differentiation in competitive market – The increasingly
competitive pharmaceutical marketplace demands constant innovation
to stand out from the crowd. Mesotherapy offers a proven means of
differentiating injection therapies through a more patient-friendly
delivery device.
- Gain market share and increase drug sales – By increasing
patient acceptance, improving compliance, and offering innovation
in the marketplace, the net result for the pharmaceutical manufacturer
is sales and market share growth.
equidyne的核心技術是液體噴射注射液，它可以用來為無針當局的藥物和疫苗投放市場。噴注所依據的原則是用機械能量來源，以創造一個釋放壓力，並不足以推動劑量的液體藥物通過一個非常小的孔，形成薄專欄液穿透皮膚，並注射到皮下組織，而無需使用針頭。
無針的優勢
- 改善病人接受治療-讓我們面對它，沒有人會喜歡注射針頭！通過消除針注射療法，最終結果是更接納病人。
- 增加病人依從-更好地接受線索，以更好地遵守.通過消除"恐懼因素"
，採取打針，病人將不太可能跳過一劑或延誤治療。
- 消除風險的銳器損傷和處置的麻煩-最近，聯邦和各州法律已授權使用安全注射液產品在衛生保健設施。無針注射是一個初級預防工具，它能消除危險意外被針頭紮傷和處置相關風險針頭注射器。
- 產品的差異化，在競爭激烈的市場-競爭日益激烈的醫藥市場需求不斷創新，脫穎而出。無針注射液提供了一個行之有效的手段，區分注射療法通過一個更有耐心友善運送裝置。
- 擴大市場份額，並增加藥品銷售-通過增加病人接受，提高遵守法律，並提供創新，在市場上，最終結果為製藥商是銷售和市場份額的增長。
|
